Short Interest in Nyxoah SA (NASDAQ:NYXH) Expands By 51.2%

Nyxoah SA (NASDAQ:NYXH) was the target of a significant growth in short interest in August. As of August 15th, there was short interest totaling 241,900 shares, agrowthof51.2% from the July 31st total of 160,000 shares. Approximately1.4% of the shares of the stock are sold short. Based on an average daily trading volume, of 87,800 shares, the days-to-cover ratio is presently 2.8 days. Based on an average daily trading volume, of 87,800 shares, the days-to-cover ratio is presently 2.8 days. Approximately1.4% of the shares of the stock are sold short.

Hedge Funds Weigh In On Nyxoah

A number of institutional investors and hedge funds have recently added to or reduced their stakes in NYXH. Vestal Point Capital LP acquired a new stake in Nyxoah during the fourth quarter worth approximately $23,394,000. Ameriprise Financial Inc. bought a new position in shares of Nyxoah during the 4th quarter valued at approximately $135,000. Kovack Advisors Inc. lifted its stake in Nyxoah by 16.5% in the 1st quarter. Kovack Advisors Inc. now owns 23,295 shares of the company’s stock worth $163,000 after purchasing an additional 3,295 shares in the last quarter. Shay Capital LLC bought a new position in shares of Nyxoah during the 2nd quarter valued at $374,000. Finally, Bank of America Corp DE lifted its position in shares of Nyxoah by 72.4% in the 2nd quarter. Bank of America Corp DE now owns 7,866 shares of the company’s stock worth $59,000 after purchasing an additional 3,303 shares during the period.

Nyxoah Stock Down 0.5%

Shares of NASDAQ:NYXH traded down $0.03 on Monday, hitting $5.90. 67,765 shares of the company’s stock were exchanged, compared to its average volume of 103,822. Nyxoah has a 1-year low of $5.55 and a 1-year high of $11.87. The firm’s 50-day moving average is $7.12 and its 200 day moving average is $7.54. The company has a debt-to-equity ratio of 0.29, a quick ratio of 2.38 and a current ratio of 2.63. The company has a market capitalization of $200.95 million, a PE ratio of -2.57 and a beta of 1.60.

Nyxoah (NASDAQ:NYXH) last released its quarterly earnings data on Monday, August 18th. The company reported ($0.63) EPS for the quarter, missing the consensus estimate of ($0.62) by ($0.01). The company had revenue of $1.58 million during the quarter, compared to analysts’ expectations of $1.33 million. Nyxoah had a negative net margin of 1,541.84% and a negative return on equity of 79.18%. Sell-side analysts predict that Nyxoah will post -1.91 EPS for the current year.

Nyxoah Company Profile

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.